INTERNATIONAL PATENT: BEIJING BAYLX PHARMACEUTICAL CO., LTD, 北京贝来药业有限公司 FILES APPLICATION FOR "PHARMACEUTICAL USE OF STEM CELL MODIFIED BASED ON SINGLE-DOMAIN ANTIBODY GENES FOR VARIOUS DISEASES"

Posted On: 2025-09-21

GENEVA, Sept. 21 -- BEIJING BAYLX PHARMACEUTICAL CO., LTD (1st To 3rd Floors, Building 5, No.16 Baoshennan Street, Daxing Biomedical Industry Base, Zhongguancun Science And Technology Park,Daxing District, Beijing 102600), 北京贝来药业有限公司 (中国北京市大兴区中关村科技园区大兴生物医药产业基地宝参南街16号院5号楼第1层至第3层) filed a patent application (PCT/CN2025/093638) for "PHARMACEUTICAL USE OF STEM CELL MODIFIED BASED ON SINGLE-DOMAIN ANTIBODY GENES FOR...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: BEIJING BAYLX PHARMACEUTICAL CO., LTD, 北京贝来药业有限公司 FILES APPLICATION FOR "PHARMACEUTICAL USE OF STEM CELL MODIFIED BASED ON SINGLE-DOMAIN ANTIBODY GENES FOR VARIOUS DISEASES"